The drug development pipeline for glioblastoma-A cross sectional assessment of the FDA Orphan Drug Product designation database.

PLoS One · 2021 · PMC8263276 · PMID 34234357

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Until 2016, the number of drugs designated for the indication glioblastoma varied, but on average displayed an increasing trend ( Fig 1 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.